Iron Overload in Thal assemia and Related Conditions: Therapeutic Goals and Assessment of Response to Chelation Therapies

Mar 1, 2017 by in HEMATOLOGY Comments Off on Iron Overload in Thal assemia and Related Conditions: Therapeutic Goals and Assessment of Response to Chelation Therapies

Transfusional iron loading inevitably results in hepatic iron accumulation, with variable extrahepatic distribution that is typically less pronounced in sickle cell disease than in thalassemia disorders. Iron chelation therapy has…

read more

Hemoglobin Gene Therapy for β-Thalassemia

Mar 1, 2017 by in HEMATOLOGY Comments Off on Hemoglobin Gene Therapy for β-Thalassemia

Allogeneic stem cell transplantation currently is the only curative option for severe β-thalassemia and sickle cell disease. Human globin gene therapy with autotransplantation of transduced human hematopoietic stem cells is…

read more

Pharmacologic Induction of Fetal Hemoglobin Production

Mar 1, 2017 by in HEMATOLOGY Comments Off on Pharmacologic Induction of Fetal Hemoglobin Production

Reactivation of fetal hemoglobin (HbF) expression is an important therapeutic option in adult patients with hemoglobin disorders. The understanding of the developmental regulation of γ-globin gene expression was followed by…

read more

Anemia, Ineffective Erythropoiesis, and Hepcidin: Interacting Factors in Abnormal Iron Metabolism Leading to Iron Overload in β-Thalassemia

Mar 1, 2017 by in HEMATOLOGY Comments Off on Anemia, Ineffective Erythropoiesis, and Hepcidin: Interacting Factors in Abnormal Iron Metabolism Leading to Iron Overload in β-Thalassemia

β-Thalassemia is a genetic disorder caused by mutations in the β-globin gene and characterized by chronic anemia caused by ineffective erythropoiesis, and accompanied by a variety of serious secondary complications…

read more
Get Clinical Tree app for offline access